TIS 0.00% 0.0¢ tissue therapies limited

Q&A

  1. 427 Posts.
    lightbulb Created with Sketch. 7
    Finally able to download Q&A posted by company. (Computer problems).
    Firstly I must say "Was that so hard?" to inform your shareholders what was happening. Company under previous management expected it couldn't raise the money it needed if people knew what was happening. I think this is actually an error of judgment, and may have found some support.

    Secondly, with the igf-1 being the sticking point, have the company ever considered producing just the scaffold on its own, and then secondly applying growth enhancers secondly, which are already available. CE mark for this would be quick and simple (comparatively), and can then work on getting the combined product approved.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.